Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-BUD: Inhaled Budesonide for BPD Prevention
NCT01895075Phase 2Withdrawn
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in bronchopulmonary dysplasia (BPD). Planned start Jan 2019; status: withdrawn.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01895075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895075.